Introduction to Health Systems brings transparency, flexibility and predictability; opens new opportunities for clinicians to rapidly deploy simulation training for new and existing endovascular therapies. STOCKHOLM, Aug. 6, 2019 /PRNewswire/ -- Mentice AB (STO: MNTC), a world leader in simulation solutions for endovascular therapies, announces today the i

NEW YORK, Aug. 6, 2019 /PRNewswire/ -- The Mesothelioma Victims Center is a national advocate for people with mesothelioma or asbestos exposure lung cancer and their

SAN CARLOS, Calif., Aug. 6, 2019 /PRNewswire/ -- SleepQuest, Inc. a leading national provider of comprehensive care management services for obstructive sleep apnea announced today that Chris Chan joined the company as Chief Marketing Officer on July 8th, 2019. 

MORRIS, Ill., Aug. 6, 2019 /PRNewswire/ -- "MRSA infections are rampant in the United States in healthcare facilities and in the community. The ongoing MRSA (Methicillin-resistant Staphyloccocus aureus) epidemic is fueling antibiotic resistance globally," states Jeanine Thomas, founder of

BETHESDA, Md., Aug. 6, 2019 /PRNewswire/ -- Lunchskins™, inventor of the Recyclable + Sealable Paper Food Storage Bags and the Reusable Food-Safe, Dishwasher-Safe Food Storage Bag, today announced a new addition to the brand's hugely successful paper bag line. The new Lunchskins Unbleached + Non-Wax Food Storage Bags will be on shelves at Container

MINNEAPOLIS, Aug. 6, 2019 /PRNewswire/ -- The Minnesota Corporate Whistleblower Center is urging a woman who is the victim of sexual assault in the wor

SOUTH SAN FRANCISCO, Calif., Aug. 6, 2019 /PRNewswire/ -- Portola Pharmaceuticals, Inc.® (Nasdaq: PTLA) today announced the Company's first sales of Ondexxya® (andexanet alfa) in Europe. These sales mark the initiation of commercial access in Europe to Ondexxya – th

RANCHO CORDOVA, Calif., Aug. 6, 2019 /PRNewswire/ -- Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cell processing and autologous cell therapies for regenerative medicine, today announced that the Company will release its financial results for the second quarter ended June 30, 2019 on

ATLANTA, Aug. 6, 2019 /PRNewswire/ -- Emil Kakkis, MD, PhD, joins the Board of Directors of Odylia Therapeutics.  Kakkis is the CEO, President and Founder of Ultragenyx Pharmaceutical Inc., which is committed to developing and commercializing treatments for rare and ultra-rare diseases. He brings to Odylia knowledge of the needs and opportunities in developing

NASHVILLE, Tenn., Aug. 6, 2019 /PRNewswire/ -- Promises Behavioral Health ("Promises"), a growing national provider of comprehensive behavioral health, substance abuse treatment and related services, today announced that John P. Hart has joined the Company as Chief Financial Officer.  Mr. Hart is an accomplished health industry financi